Neuralink’s last official post-money valuation stood at approximately $9 billion following its $650 million Series E round in mid-2025. Secondary-market transactions have since implied significantly higher levels, with reported prices ranging from $29 billion to $42 billion in recent months and occasional bids near $60 billion, reflecting strong investor demand for Musk-linked assets amid clinical-trial progress. No new primary funding round has been announced in 2026, so any near-term valuation shift by the August 31 deadline would likely depend on rapid secondary-price appreciation or an unexpected financing close—both low-probability events given the compressed two-week window and absence of disclosed catalysts. Market-implied odds therefore hinge on whether traders view secondary benchmarks or formal round pricing as the resolution trigger.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoCurrent Valuation:$44.74B
+253.56%Powered by
$13,578 Wol.
Sep 1, 2026
↑$70B
1%
↑$60B
6%
↑$55B
20%
↑$50B
23%
↑$47.5B
43%
↑$45B
85%
↓$42.5B
39%
↓$40B
35%
↓$35B
7%
Current Valuation:$44.74B
+253.56%Powered by
$13,578 Wol.
↑$70B
$187 Wol.
1%
↑$60B
$373 Wol.
6%
↑$55B
$70 Wol.
20%
↑$50B
$4,970 Wol.
23%
↑$47.5B
$963 Wol.
43%
↑$45B
$1,153 Wol.
85%
↓$42.5B
$897 Wol.
39%
↓$40B
$4,043 Wol.
35%
↓$35B
$922 Wol.
7%
This market will resolve to "Yes" if Neuralink's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and August 31, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No".
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on the calendar date following the specified date, this market will remain open until 11:59 PM ET on the third business day following the specified date. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company’s public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined through appropriate calculation using official regular-hours trading prices published for the company’s listed equities on its primary exchange for any trading day during the specified period, multiplied by the company's total number of shares outstanding at the relevant time. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings).
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-782c0a32-4727-4097-a40b-9a2602f243e7/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be the relevant Market Cap figure displayed on https://www.nasdaq.com/ as well as official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.Neuralink’s last official post-money valuation stood at approximately $9 billion following its $650 million Series E round in mid-2025. Secondary-market transactions have since implied significantly higher levels, with reported prices ranging from $29 billion to $42 billion in recent months and occasional bids near $60 billion, reflecting strong investor demand for Musk-linked assets amid clinical-trial progress. No new primary funding round has been announced in 2026, so any near-term valuation shift by the August 31 deadline would likely depend on rapid secondary-price appreciation or an unexpected financing close—both low-probability events given the compressed two-week window and absence of disclosed catalysts. Market-implied odds therefore hinge on whether traders view secondary benchmarks or formal round pricing as the resolution trigger.
This market will resolve to "Yes" if Neuralink's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and August 31, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No".
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on the calendar date following the specified date, this market will remain open until 11:59 PM ET on the third business day following the specified date. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company’s public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined through appropriate calculation using official regular-hours trading prices published for the company’s listed equities on its primary exchange for any trading day during the specified period, multiplied by the company's total number of shares outstanding at the relevant time. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings).
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-782c0a32-4727-4097-a40b-9a2602f243e7/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be the relevant Market Cap figure displayed on https://www.nasdaq.com/ as well as official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on the calendar date following the specified date, this market will remain open until 11:59 PM ET on the third business day following the specified date. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company’s public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined through appropriate calculation using official regular-hours trading prices published for the company’s listed equities on its primary exchange for any trading day during the specified period, multiplied by the company's total number of shares outstanding at the relevant time. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings).
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-782c0a32-4727-4097-a40b-9a2602f243e7/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be the relevant Market Cap figure displayed on https://www.nasdaq.com/ as well as official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
Rynek otwarty: Jul 31, 2026, 7:29 PM ET
Wolumen
$13,578Data zakończenia
Sep 1, 2026Rynek otwarty
Jul 31, 2026, 7:29 PM ETŹródło rozstrzygnięcia
https://fe.secondmarket.com/companies/company-782c0a32-4727-4097-a40b-9a2602f243e7/dataResolver
0x65070BE91...This market will resolve to "Yes" if Neuralink's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and August 31, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No".
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on the calendar date following the specified date, this market will remain open until 11:59 PM ET on the third business day following the specified date. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company’s public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined through appropriate calculation using official regular-hours trading prices published for the company’s listed equities on its primary exchange for any trading day during the specified period, multiplied by the company's total number of shares outstanding at the relevant time. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings).
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-782c0a32-4727-4097-a40b-9a2602f243e7/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be the relevant Market Cap figure displayed on https://www.nasdaq.com/ as well as official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.Neuralink’s last official post-money valuation stood at approximately $9 billion following its $650 million Series E round in mid-2025. Secondary-market transactions have since implied significantly higher levels, with reported prices ranging from $29 billion to $42 billion in recent months and occasional bids near $60 billion, reflecting strong investor demand for Musk-linked assets amid clinical-trial progress. No new primary funding round has been announced in 2026, so any near-term valuation shift by the August 31 deadline would likely depend on rapid secondary-price appreciation or an unexpected financing close—both low-probability events given the compressed two-week window and absence of disclosed catalysts. Market-implied odds therefore hinge on whether traders view secondary benchmarks or formal round pricing as the resolution trigger.
This market will resolve to "Yes" if Neuralink's private market valuation, as measured by the NPM Price reported by Nasdaq Private Market, LLC (NPM) for any date between market creation and August 31, 2026, reaches or exceeds the listed amount. Otherwise, this market will resolve to "No".
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on the calendar date following the specified date, this market will remain open until 11:59 PM ET on the third business day following the specified date. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company’s public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined through appropriate calculation using official regular-hours trading prices published for the company’s listed equities on its primary exchange for any trading day during the specified period, multiplied by the company's total number of shares outstanding at the relevant time. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings).
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-782c0a32-4727-4097-a40b-9a2602f243e7/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be the relevant Market Cap figure displayed on https://www.nasdaq.com/ as well as official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on the calendar date following the specified date, this market will remain open until 11:59 PM ET on the third business day following the specified date. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company’s public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined through appropriate calculation using official regular-hours trading prices published for the company’s listed equities on its primary exchange for any trading day during the specified period, multiplied by the company's total number of shares outstanding at the relevant time. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings).
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here: (https://fe.secondmarket.com/companies/company-782c0a32-4727-4097-a40b-9a2602f243e7/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be the relevant Market Cap figure displayed on https://www.nasdaq.com/ as well as official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
Wolumen
$13,578Data zakończenia
Sep 1, 2026Rynek otwarty
Jul 31, 2026, 7:29 PM ETŹródło rozstrzygnięcia
https://fe.secondmarket.com/companies/company-782c0a32-4727-4097-a40b-9a2602f243e7/dataResolver
0x65070BE91...Neuralink’s last official post-money valuation stood at approximately $9 billion following its $650 million Series E round in mid-2025. Secondary-market transactions have since implied significantly higher levels, with reported prices ranging from $29 billion to $42 billion in recent months and occasional bids near $60 billion, reflecting strong investor demand for Musk-linked assets amid clinical-trial progress. No new primary funding round has been announced in 2026, so any near-term valuation shift by the August 31 deadline would likely depend on rapid secondary-price appreciation or an unexpected financing close—both low-probability events given the compressed two-week window and absence of disclosed catalysts. Market-implied odds therefore hinge on whether traders view secondary benchmarks or formal round pricing as the resolution trigger.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania